Page last updated: 2024-08-24

atorvastatin and Lupus Nephritis

atorvastatin has been researched along with Lupus Nephritis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cook, HT; Ehrenstein, MR; Jury, EC; Lawman, S; Mauri, C	1
Cairns, T; Cook, HT; Elliot, V	1

Other Studies

2 other study(ies) available for atorvastatin and Lupus Nephritis

Article	Year
Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice. Journal of immunology (Baltimore, Md. : 1950), 2004, Dec-15, Volume: 173, Issue:12 Topics: Animals; Atorvastatin; B-Lymphocyte Subsets; Cell Proliferation; Cholesterol; Crosses, Genetic; Down-Regulation; Female; Growth Inhibitors; Heptanoic Acids; Histocompatibility Antigens Class II; Hypolipidemic Agents; Immunosuppressive Agents; Kidney; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred NZB; Pyrroles; Spleen; T-Lymphocytes; Time Factors	2004
Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:1 Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Biopsy, Needle; Disease Progression; Follow-Up Studies; Hematuria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Organelles; Plasma Exchange; Pyrroles; Sclerosis; Severity of Illness Index; Software Design	2006

Article

Year

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice.

Journal of immunology (Baltimore, Md. : 1950), 2004, Dec-15, Volume: 173, Issue:12

Topics: Animals; Atorvastatin; B-Lymphocyte Subsets; Cell Proliferation; Cholesterol; Crosses, Genetic; Down-Regulation; Female; Growth Inhibitors; Heptanoic Acids; Histocompatibility Antigens Class II; Hypolipidemic Agents; Immunosuppressive Agents; Kidney; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred NZB; Pyrroles; Spleen; T-Lymphocytes; Time Factors

2004

Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:1

Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atorvastatin; Biopsy, Needle; Disease Progression; Follow-Up Studies; Hematuria; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Organelles; Plasma Exchange; Pyrroles; Sclerosis; Severity of Illness Index; Software Design

2006